Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | BCHE | P06276 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | MMP1 | P03956 | 1/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | MMP3 | P08254 | 1/20 | 0.33 |
| ▸ | MMP8 | P22894 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.31 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1373682 | 0.90 | ALDH1A1 (0.41) | LMNANPC1TSHRHPGDALOX15 | |
| SCHEMBL1374472 | 0.85 | ALDH1A1 (0.47) | LMNATSHRHPGDMAPK1 | |
| SCHEMBL1377034 | 0.84 | LMNA (0.52) | LMNANPC1TSHRHPGDRAB9A | |
| SCHEMBL1374437 | 0.83 | — | — | |
| SCHEMBL1374337 | 0.82 | ALDH1A1 (0.43) | — | |
| SCHEMBL1374428 | 0.81 | BCHE (0.33) | BCHEACHE | |
| SCHEMBL14759103 | 0.80 | BCHE (0.43) | LMNANPC1TSHRRAB9ABCHE | |
| SCHEMBL16467221 | 0.79 | CNR1 (0.30) | — | |
| SCHEMBL1377240 | 0.77 | EPHX2 (0.32) | HPGD | |
| SCHEMBL8096461 | 0.75 | FFAR3 (0.40) | LMNATSHRALOX15HSD17B10PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2568019-B1 | Inkjet ink | JNC CORP (JP) | 2015-09-02 | — | — | EP | disclosed |
| US-20150119604-A1 | METHOD FOR PRODUCING BETA-ALKOXYPROPIONAMIDE | IDEMITSU KOSAN CO., LTD. (JP) | 2015-04-30 | — | — | US | disclosed |
| EP-2837619-A1 | METHOD FOR PRODUCING BETA -ALKOXYPROPIONAMIDE | Idemitsu Kosan Co., Ltd (JP) | 2015-02-18 | — | — | EP | disclosed |
| US-8563495-B2 | Resist remover composition and method for removing resist using same | IDEMITSU KOSAN CO., LTD. (JP) | 2013-10-22 | — | — | US | disclosed |
| EP-2568019-A1 | Inkjet ink | JNC Corporation (JP) | 2013-03-13 | — | — | EP | disclosed |
| US-20110287995-A1 | RESIST REMOVER COMPOSITION AND METHOD FOR REMOVING RESIST USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2011-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150119604-A1 | METHOD FOR PRODUCING BETA-ALKOXYPROPIONAMIDE | HACL2, APEH, NAAA | LMNA 792/4885NPC1 1936/4885TSHR 1284/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.